Marta Perek-Polnik
Overview
Explore the profile of Marta Perek-Polnik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
1698
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee J, Tao R, You Z, Haldipur P, Erickson A, Farooq H, et al.
Nat Genet
. 2025 Jan;
57(1):88-102.
PMID: 39753768
Transcription factors are frequent cancer driver genes, exhibiting noted specificity based on the precise cell of origin. We demonstrate that ZIC1 exhibits loss-of-function (LOF) somatic events in group 4 (G4)...
2.
Johnston M, Lee J, Hu B, Nikolic A, Hasheminasabgorji E, Baguette A, et al.
Cell
. 2024 Jul;
187(18):4926-4945.e22.
PMID: 38986619
Posterior fossa group A (PFA) ependymoma is a lethal brain cancer diagnosed in infants and young children. The lack of driver events in the PFA linear genome led us to...
3.
Perek-Polnik M, Cochrane A, Wang J, Chojnacka M, Drogosiewicz M, Filipek I, et al.
Children (Basel)
. 2023 Aug;
10(8).
PMID: 37628386
Craniospinal irradiation (CSI) has been a major component of the standard of care treatment backbone for childhood medulloblastoma. However, chemotherapy regimens have varied based on protocol, patient age, and molecular...
4.
Lach K, Kowal A, Perek-Polnik M, Jakubczyk P, Arthur C, Bal W, et al.
Molecules
. 2023 Mar;
28(5).
PMID: 36903631
Introduction: Medulloblastoma (MB) is the most common malignant tumor of the central nervous system in childhood. FTIR spectroscopy provides a holistic view of the chemical composition of biological samples, including...
5.
Moszczynska E, Kunecka K, Baszynska-Wilk M, Perek-Polnik M, Majak D, Grajkowska W
Front Endocrinol (Lausanne)
. 2022 Jun;
13:868558.
PMID: 35669693
Background: Pituitary stalk thickening (PST) is a rare abnormality in the pediatric population. Its etiology is heterogeneous. The aim of the study was to identify important clinical, radiological and endocrinological...
6.
Karwacki M, Wysocki M, Perek-Polnik M, Jatczak-Gaca A
Arch Med Sci
. 2021 Sep;
17(5):1221-1231.
PMID: 34522251
Coordinated medical care offered in Poland for patients suffering from neurofibromatosis type 1 and related RASopathies combines complex multispecialty consultation with permanent supervision and the patient's oriented longitudinal care. Neurofibromatosis...
7.
Lastowska M, Matyja E, Sobocinska A, Wojtas B, Niemira M, Szalkowska A, et al.
J Pathol Clin Res
. 2021 Jul;
7(6):565-576.
PMID: 34314101
The majority of supratentorial ependymomas in children contain oncogenic fusions, such as ZFTA-RELA or YAP1-MAMLD1. In contrast, posterior fossa (PF) ependymomas lack recurrent somatic mutations and are classified based on...
8.
von Hoff K, Haberler C, Schmitt-Hoffner F, Schepke E, de Rojas T, Jacobs S, et al.
Neuro Oncol
. 2021 Jun;
23(9):1597-1611.
PMID: 34077956
Background: Only few data are available on treatment-associated behavior of distinct rare CNS embryonal tumor entities previously treated as "CNS-primitive neuroectodermal tumors" (CNS-PNET). Respective data on specific entities, including CNS...
9.
Lastowska M, Trubicka J, Sobocinska A, Wojtas B, Niemira M, Szalkowska A, et al.
Acta Neuropathol Commun
. 2020 Jul;
8(1):105.
PMID: 32650833
Four molecular types of rare central nervous system (CNS) tumors have been recently identified by gene methylation profiling: CNS Neuroblastoma with FOXR2 activation (CNS NB-FOXR2), CNS Ewing Sarcoma Family Tumor...
10.
Lastowska M, Trubicka J, Karkucinska-Wieckowska A, Kaleta M, Tarasinska M, Perek-Polnik M, et al.
Brain Tumor Pathol
. 2018 Dec;
36(1):1-6.
PMID: 30523493
Expression of the ALK gene strongly correlates with the WNT-activated medulloblastomas, which are routinely identified by detection of CTNNB1 mutation. However, some tumors have mutations in other than CTNNB1 genes....